rs57854058

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_030973.4(MED25):​c.2031G>A​(p.Ala677Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00967 in 1,611,934 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 24 hom., cov: 33)
Exomes 𝑓: 0.0092 ( 93 hom. )

Consequence

MED25
NM_030973.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.73

Publications

3 publications found
Variant links:
Genes affected
MED25 (HGNC:28845): (mediator complex subunit 25) This gene encodes a component of the transcriptional coactivator complex termed the Mediator complex. This complex is required for transcription of most RNA polymerase II-dependent genes. The encoded protein plays a role in chromatin modification and in preinitiation complex assembly. Mutations in this gene are associated with Charcot-Marie-Tooth disease type 2B2. [provided by RefSeq, Apr 2010]
MED25 Gene-Disease associations (from GenCC):
  • congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Charcot-Marie-Tooth disease type 2B2
    Inheritance: AR Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.029).
BP6
Variant 19-49836291-G-A is Benign according to our data. Variant chr19-49836291-G-A is described in ClinVar as Benign. ClinVar VariationId is 138200.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.73 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0143 (2172/152208) while in subpopulation AFR AF = 0.0285 (1182/41540). AF 95% confidence interval is 0.0271. There are 24 homozygotes in GnomAd4. There are 965 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED25NM_030973.4 linkc.2031G>A p.Ala677Ala synonymous_variant Exon 17 of 18 ENST00000312865.10 NP_112235.2 Q71SY5-1
MED25NM_001378355.1 linkc.2031G>A p.Ala677Ala synonymous_variant Exon 17 of 18 NP_001365284.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED25ENST00000312865.10 linkc.2031G>A p.Ala677Ala synonymous_variant Exon 17 of 18 1 NM_030973.4 ENSP00000326767.5 Q71SY5-1

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2167
AN:
152090
Hom.:
24
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0284
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.0133
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00958
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.00817
AC:
1965
AN:
240568
AF XY:
0.00765
show subpopulations
Gnomad AFR exome
AF:
0.0306
Gnomad AMR exome
AF:
0.00754
Gnomad ASJ exome
AF:
0.00951
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00186
Gnomad NFE exome
AF:
0.00960
Gnomad OTH exome
AF:
0.0118
GnomAD4 exome
AF:
0.00919
AC:
13412
AN:
1459726
Hom.:
93
Cov.:
32
AF XY:
0.00892
AC XY:
6479
AN XY:
726146
show subpopulations
African (AFR)
AF:
0.0300
AC:
1003
AN:
33468
American (AMR)
AF:
0.00753
AC:
336
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
0.0103
AC:
269
AN:
26082
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.00147
AC:
127
AN:
86152
European-Finnish (FIN)
AF:
0.00215
AC:
112
AN:
52096
Middle Eastern (MID)
AF:
0.0131
AC:
75
AN:
5742
European-Non Finnish (NFE)
AF:
0.00973
AC:
10812
AN:
1111604
Other (OTH)
AF:
0.0113
AC:
678
AN:
60256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
778
1556
2333
3111
3889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0143
AC:
2172
AN:
152208
Hom.:
24
Cov.:
33
AF XY:
0.0130
AC XY:
965
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0285
AC:
1182
AN:
41540
American (AMR)
AF:
0.0133
AC:
203
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
43
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10614
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00958
AC:
651
AN:
67962
Other (OTH)
AF:
0.0175
AC:
37
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
102
203
305
406
508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0110
Hom.:
5
Bravo
AF:
0.0156
Asia WGS
AF:
0.00346
AC:
13
AN:
3478
EpiCase
AF:
0.00889
EpiControl
AF:
0.0107

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 20, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Charcot-Marie-Tooth disease type 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome Benign:1
Nov 23, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
6.0
DANN
Benign
0.48
PhyloP100
-1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57854058; hg19: chr19-50339548; COSMIC: COSV57203835; COSMIC: COSV57203835; API